Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Students and teachers march in France on biggest day of high school protests
'Ghost particle' hunter Francis Halzen wins 2026 Nobel Physics Prize
Saudi Arabia says 2 airports targeted as fighting with Yemen's Houthis escalates
Indian opposition marches in protest seeking resignation of election chief
Cornell students stage rally in support of 'Jane Doe'
